SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001831283-23-000117
Filing Date
2023-10-30
Accepted
2023-10-30 16:16:40
Documents
15
Period of Report
2023-10-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lian-20231024.htm   iXBRL 8-K 38697
2 EX-99.1 exhibit991pressreleaseissu.htm EX-99.1 20591
3 EX-99.2 exhibit992proformafinancia.htm EX-99.2 166352
7 image.jpg GRAPHIC 10103
  Complete submission text file 0001831283-23-000117.txt   393407

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lian-20231024.xsd EX-101.SCH 1901
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lian-20231024_lab.xml EX-101.LAB 25850
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lian-20231024_pre.xml EX-101.PRE 13581
9 EXTRACTED XBRL INSTANCE DOCUMENT lian-20231024_htm.xml XML 2966
Mailing Address 103 CARNEGIE CENTER DRIVE, SUITE 309 PRINCETON NJ 08540
Business Address 103 CARNEGIE CENTER DRIVE, SUITE 309 PRINCETON NJ 08540 (609) 486-2308
LianBio (Filer) CIK: 0001831283 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40947 | Film No.: 231360440
SIC: 2834 Pharmaceutical Preparations